The Use of Lung Ultrasonography in COVID-19 Patients

The Significance of Lung Ultrasonography in the Follow-up and Treatment of COVID-19 Patients With Respiratory Failure

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04432051

Enrollment

100

Registered

2020-06-16

Start date

2020-05-26

Completion date

2020-08-10

Last updated

2022-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ultrasonography

Keywords

lung ultrasonography, intensive care unit, position, COVID-19

Brief summary

In COVID-19 patients hospitalized in the intensive care unit due to respiratory failure, lung ultrasonography will be tried to be given an appropriate position that will effectively use lung capacity and its effect on oxygenation will be investigated.

Detailed description

In this study, the COVID-19 patients hospitalized in the intensive care unit due to respiratory failure will be evaluated. Participants will be divided into two groups as patients undergoing lung ultrasonography (Group Ultrasonography ) and those without lung ultrasonography (Group Control). While performing lung ultrasonography, each hemithorax will be evaluated using anterior axillary line and posterior axillary line into anterior, lateral and posterior region, and each region will be divided into 6 quadrants, upper and lower. Each hemithorax will be scanned by the investigators, scored in 6 regions using a convex ultrasonography probe with the Lung Ultrasound Score (LUS score). Participants in both groups will be evaluated by comparing arterial blood gas analyzes before examination (with/without ultrasonography), at the 2nd and 12th hours. Is there any change in arterial blood gas values such as PO2 and PCO2 at 0, 2 and 12 hours so that oxygenation and ventilation between Group Ultrasonograpy and Group Control will be evaluated?

Interventions

BEHAVIORALmechanical ventilator settings and position

Mechanical ventilation settings and patient position will be re-evaluated

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

TRIPLE (Subject, Caregiver, Outcomes Assessor)

Intervention model description

patients will be divided into two groups, those with and without ultrasound.

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients have been diagnosed with COVID 19 * Patients in the intensive care unit over the age of 18

Exclusion criteria

* Patients not diagnosed with COVID 19 * Patients with cardiac problems * Patients with renal problems

Design outcomes

Primary

Measure	Time frame	Description
Change in PO2 values	12 hours	Effect of positioning on ultrasound guidance on oxygenation assessed by changes between pO2 values.

Secondary

Measure	Time frame	Description
Change in PCO2 values	12 hours	Effect of positioning on ultrasound guidance on ventilation assessed by changes between pCO2 values.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026